- 全部删除
- 您的购物车当前为空
4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid is an unusual polyunsaturated fatty acid (PUFA) generated during the synthesis of docosahexaenoic acid-d5 . While the physiological properties of this compound are not known, dietary intake of n-3 long-chain PUFAs provides potential health benefits.
4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid is an unusual polyunsaturated fatty acid (PUFA) generated during the synthesis of docosahexaenoic acid-d5 . While the physiological properties of this compound are not known, dietary intake of n-3 long-chain PUFAs provides potential health benefits.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 μg | 待估 | 35日内发货 | |
100 μg | 待估 | 35日内发货 | |
500 μg | 待估 | 35日内发货 | |
1 mg | 待估 | 35日内发货 |
4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic Acid 相关产品
产品描述 | 4(Z),7(Z),10(Z),13(Z),16(Z)-Nonadecapentaenoic acid is an unusual polyunsaturated fatty acid (PUFA) generated during the synthesis of docosahexaenoic acid-d5 . While the physiological properties of this compound are not known, dietary intake of n-3 long-chain PUFAs provides potential health benefits. |
分子量 | 288.42 |
分子式 | C19H28O2 |
CAS No. | 136156-13-3 |
密度 | 0.946 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
溶解度信息 | DMF: 100 mg/mL (346.72 mM), Sonication is recommended. PBS (pH 7.2): 100 μg/mL, Sonication is recommended. 0.15 M Tris-HCl (pH 8.5): 1 mg/mL (3.47 mM), Sonication is recommended. Ethanol: 100 mg/mL (346.72 mM), Sonication is recommended. DMSO: 100 mg/mL (346.72 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMF/Ethanol/DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容